Mutations in MYH7 reduce the force generating capacity of sarcomeres in human familial hypertrophic cardiomyopathy.
about
Targets for therapy in sarcomeric cardiomyopathiesResearch priorities in sarcomeric cardiomyopathiesPathophysiological concepts in the congenital myopathies: blurring the boundaries, sharpening the focusModelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytesRemodeling of the heart in hypertrophy in animal models with myosin essential light chain mutations.Human pluripotent stem cells: Prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair.Rapid large-scale purification of myofilament proteins using a cleavable His6-tag.Isolation and Mechanical Measurements of Myofibrils from Human Induced Pluripotent Stem Cell-Derived CardiomyocytesMuscle dysfunction in hypertrophic cardiomyopathy: what is needed to move to translation?Hypertrophic and dilated cardiomyopathy: four decades of basic research on muscle lead to potential therapeutic approaches to these devastating genetic diseases.Structural implications of β-cardiac myosin heavy chain mutations in human disease.Contractile Defect Caused by Mutation in MYBPC3 Revealed under Conditions Optimized for Human PSC-Cardiomyocyte FunctionSelective phosphorylation of PKA targets after β-adrenergic receptor stimulation impairs myofilament function in Mybpc3-targeted HCM mouse model.ENerGetIcs in hypertrophic cardiomyopathy: traNslation between MRI, PET and cardiac myofilament function (ENGINE study).Life-long tailoring of management for patients with hypertrophic cardiomyopathy : Awareness and decision-making in changing scenarios.Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.Hypothesis and theory: mechanical instabilities and non-uniformities in hereditary sarcomere myopathies.Cardiomyocyte Hypocontractility and Reduced Myofibril Density in End-Stage Pediatric Cardiomyopathy.Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.Sexual dimorphic response to exercise in hypertrophic cardiomyopathy-associated MYBPC3-targeted knock-in mice.Burst-Like Transcription of Mutant and Wildtype MYH7-Alleles as Possible Origin of Cell-to-Cell Contractile Imbalance in Hypertrophic Cardiomyopathy.Faster cross-bridge detachment and increased tension cost in human hypertrophic cardiomyopathy with the R403Q MYH7 mutation
P2860
Q27027023-F6A30681-2463-41DA-A30F-C38122805AE0Q27694507-B850B464-67FE-49E5-85A6-BD6832E93CC2Q28087567-7008CBF3-0546-4379-8552-E56D5DAC2679Q28255887-CD0E7548-0444-4D63-A857-4A586517DA2EQ34219487-420DCCB2-EBD0-42A0-AF6C-FCA3E69F72B0Q36279078-A2D2D3D9-CC56-46C3-B62A-AA25F8F17E61Q36339414-54606CAB-049B-402F-B023-3554D44C4EC2Q37014695-82BE143D-8AD8-418C-AC98-1E4BF55142D0Q37696227-E809FE83-113B-47CD-8482-1442116C2780Q37701056-F77D354F-11FE-4F9E-B08E-5E46E934E6DBQ38240077-4E24DE3D-D93B-4A55-9ADB-4DBF889ACFD0Q38826141-9FB77947-A6D8-45CA-AB7D-25EEA3C01946Q40042653-B3A6DC43-BB6C-43AB-8C2F-BD1B66E0CDE7Q41815143-28A8590C-9176-4EE9-B4BC-FCDBD93A43E8Q42320941-C5CE1E9F-B648-446B-A1DD-A8497EA5FFB6Q42515078-7DD0016B-C885-404C-BDF6-BDAEA870ABE9Q42877248-B04EBA35-60E5-4248-90C0-4F8E93654CAEQ47194567-A6B40575-FBAD-48F1-8EE4-9EDFD7785C2AQ48177445-DB85578D-3F6C-454D-BBE7-A8FF9DC09449Q51128798-C734E487-39BB-4F44-89BE-EF9B9D35773EQ52804423-5E73D855-F1B9-4DF9-8E31-8782CF9FF292Q58087435-3918420F-1D3D-47E7-965E-80FF9EBD5CBF
P2860
Mutations in MYH7 reduce the force generating capacity of sarcomeres in human familial hypertrophic cardiomyopathy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Mutations in MYH7 reduce the f ...... l hypertrophic cardiomyopathy.
@en
Mutations in MYH7 reduce the f ...... l hypertrophic cardiomyopathy.
@nl
type
label
Mutations in MYH7 reduce the f ...... l hypertrophic cardiomyopathy.
@en
Mutations in MYH7 reduce the f ...... l hypertrophic cardiomyopathy.
@nl
prefLabel
Mutations in MYH7 reduce the f ...... l hypertrophic cardiomyopathy.
@en
Mutations in MYH7 reduce the f ...... l hypertrophic cardiomyopathy.
@nl
P2093
P2860
P50
P356
P1476
Mutations in MYH7 reduce the f ...... l hypertrophic cardiomyopathy.
@en
P2093
Beatrice Scellini
Chiara Tesi
Claudia Ferrara
Corrado Poggesi
Cris dos Remedios
E Rosalie Witjas-Paalberends
Hans W M Niessen
Kelly Stam
Marjon van Slegtenhorst
Mark Hazebroek
P2860
P304
P356
10.1093/CVR/CVT119
P577
2013-05-13T00:00:00Z